Wall Street Journal |
AstraZeneca's Asthma Drug Shows Positive Results
Wall Street Journal Bing Yao, head of respiratory medicine at AstraZeneca's MedImmune unit, said benralizumab acted directly on the cells that are thought to cause attacks in patients with severe asthma. He said the Glaxo and Teva drugs, by contrast, act indirectly by … AstraZeneca set to go head to head against GSK with asthma drug AstraZeneca asthma drug hits goal, to enter competitive market AstraZeneca's asthma biologic hits PhIII target, but still behind rivals |
View full post on asthma – Google News